In the European Union, a rare disease is defined as one affecting fewer than 5 out of 10,000 members of the general population…

Honor women’s significant achievements in science and place a much-needed focus on girls entering Science, Technology, Engineering, and Mathematics (STEM) careers.

Ashley Hunter and Anna Yanaeva led an engaging discussion on the importance of “Utilising CROs for Effective Planning and Execution of Clinical Development”.

Clear communication is essential to drug development. At Aixial Group, our experienced medical writers know how to turn complex scientific data into clear, accurate documents.

Breakthrough — Radiopharmaceutical therapy represents a novel approach to treating cancer, utilising radioactive atoms to target and destroy malignant cells with precision, without affecting the patient’s healthy tissues.

In recognition of Breast Cancer Awareness Month, Ashley Hunter, Head of Strategic Development and Delivery, offers valuable insights on the importance of early detection, ongoing challenges, and how Aixial Group is actively supporting the fight against breast cancer.

Insights from Matilde Thye Kveiborg, Director of Medical Writing and Tanja Jensen, Senior Medical Writer

At the bottom of the EBM hierarchy, mechanistic evidence is not highly valued by the HTA bodies responsible for…

Aixial FSP models: Expand your data management and biostatistics capabilities Whatever your existing study team structure and study data output…

Data Science & Analytics Data science and analytics solutions to fit your needs perfectly. Enhance the power of your trials…

Our experience in First-In-Human and Early Phase Oncology Trials Overview of Aixial Group’s in-depth experience in the areas of First-In-…

Top 10 Things to Look for in a Specialist Data & Analytics CRO Partner This helpful resource takes the guess…